Mechanisms and Genetics of Drug Transport

作者: Joseph A. Ware , Lei Zhang , Shiew-Mei Huang

DOI: 10.1016/B978-0-12-385471-1.00014-3

关键词:

摘要: The processes of drug absorption, distribution, metabolism, and excretion (ADME) include transport steps that are mediated by membrane-bound carriers or transporters. Over 400 membrane transporters have been annotated in the human genome, belonging to two major superfamilies: ATP-Binding Cassette (ABC) Solute Carrier (SLC). Most cloned, characterized, localized tissues polarized cellular domains (apical basolateral) body. physiological roles supplying nutrients, removing waste products, maintenance cell homeostasis, signal transduction, energy maintain motility, etc. Although more than identified, only approximately 30 known be important for transport. Numerous preclinical clinical studies now suggest is an determinant pharmacokinetics (PK) pharmacodynamics (PD) because mechanisms control access many drugs various their site action. In some instances, may represent rate-limiting step elimination, involved drug–drug interactions. There growing appreciation importance understanding impact on development role determining efficacy toxicity outcomes.

参考文章(129)
Richard B Kim, Drug transporters in HIV Therapy. Topics in HIV medicine : a publication of the International AIDS Society, USA. ,vol. 11, pp. 136- ,(2003)
Mark J. Dresser, Lei Zhang, Kathleen M. Giacomini, Molecular and Functional Characteristics of Cloned Human Organic Cation Transporters Pharmaceutical biotechnology. ,vol. 12, pp. 441- 469 ,(2002) , 10.1007/0-306-46812-3_15
Thomas J. Urban, Kathleen M. Giacomini, Organic Cation Transporters Drug Transporters. pp. 11- 33 ,(2006) , 10.1002/9780470140505.CH2
John D Schuetz, Michele C Connelly, Daxi Sun, Sheela G Paibir, Patricia M Flynn, RV Srinivas, Alok Kumar, Arnold Fridland, None, MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nature Medicine. ,vol. 5, pp. 1048- 1051 ,(1999) , 10.1038/12487
Hiroyuki Kusuhara, Hidetoshi Furuie, Akihiro Inano, Akihiro Sunagawa, Saiko Yamada, Chunyong Wu, Shinya Fukizawa, Nozomi Morimoto, Ichiro Ieiri, Mariko Morishita, Kiminobu Sumita, Hiroshi Mayahara, Takuya Fujita, Kazuya Maeda, Yuichi Sugiyama, Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP. British Journal of Pharmacology. ,vol. 166, pp. 1793- 1803 ,(2012) , 10.1111/J.1476-5381.2012.01887.X
SLCO1B1 variants and statin-induced myopathy--a genomewide study The New England Journal of Medicine. ,vol. 359, pp. 789- 799 ,(2008) , 10.1056/NEJMOA0801936
Sandra S. Strautnieks, Laura N. Bull, Alexander S. Knisely, Samuel A. Kocoshis, Niklas Dahl, Henrik Arnell, Etienne Sokal, Karine Dahan, Sarah Childs, Victor Ling, M. Stuart Tanner, Amir F. Kagalwalla, Antal Németh, Joanna Pawlowska, Alastair Baker, Giorgina Mieli-Vergani, Nelson B. Freimer, R. Mark Gardiner, Richard J. Thompson, A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis Nature Genetics. ,vol. 20, pp. 233- 238 ,(1998) , 10.1038/3034
A Kalliokoski, M Niemi, Impact of OATP transporters on pharmacokinetics British Journal of Pharmacology. ,vol. 158, pp. 693- 705 ,(2009) , 10.1111/J.1476-5381.2009.00430.X
Wenche Gorset, Kathleen M. Giacomini, Lei Zhang, Mark J. Dresser, The interaction of n-tetraalkylammonium compounds with a human organic cation transporter, hOCT1. Journal of Pharmacology and Experimental Therapeutics. ,vol. 288, pp. 1192- 1198 ,(1999)